ADAMS STREET PARTNERS LLC - Q3 2023 holdings

$286 Million is the total value of ADAMS STREET PARTNERS LLC's 14 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 66.7% .

 Value Shares↓ Weighting
PCTY SellPaylocity Holding Corporation$103,280,460
-4.6%
568,412
-3.2%
36.08%
+27.4%
RMNI  Rimini Street, Inc.$51,843,953
-54.1%
23,565,4330.0%18.11%
-38.6%
PDD NewPDD Holdings, Inc.ads$29,239,571298,150
+100.0%
10.22%
QTWO  Q2 Holdings, Inc.$25,091,926
+4.4%
777,5620.0%8.77%
+39.5%
SellMineralys Therapeutics, Inc.$21,895,149
-46.9%
2,302,329
-4.8%
7.65%
-29.1%
SellVacasa, Inc.$18,764,501
+47.1%
8,631,670
-54.0%
6.56%
+96.4%
SellIcosavax, Inc.$16,894,721
-22.0%
2,179,964
-0.0%
5.90%
+4.2%
FUSN  Fusion Pharmaceuticals, Inc.$7,664,303
-44.3%
2,947,8090.0%2.68%
-25.6%
CRVS  Corvus Pharmaceuticals, Inc.$4,782,399
-36.2%
3,275,6160.0%1.67%
-14.8%
CXM NewSprinklr, Inc.$2,961,926214,012
+100.0%
1.04%
PATH SellUiPath, Inc.$1,949,753
-66.9%
113,954
-68.0%
0.68%
-55.8%
BuyFreshworks Inc.$1,212,371
+126.5%
60,862
+99.9%
0.42%
+202.9%
AFRM NewAffirm Holdings, Inc.$374,56517,610
+100.0%
0.13%
NewBraze, Inc.$289,3526,192
+100.0%
0.10%
ExitArcellx, Inc.$0-22,924
-100.0%
-0.19%
MIRM ExitMirum Pharmaceuticals, Inc.$0-29,849
-100.0%
-0.20%
ExitSamsara, Inc.$0-36,681
-100.0%
-0.27%
PGNY ExitProgyny, Inc.$0-29,858
-100.0%
-0.31%
FLYW ExitFlywire Corporation$0-147,336
-100.0%
-1.20%
ExitRobinhood Markets, Inc.$0-482,220
-100.0%
-1.26%
CFLT ExitConfluent, Inc.$0-213,798
-100.0%
-1.97%
ZI ExitZoomInfo Technologies Inc.$0-520,631
-100.0%
-3.46%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Paylocity Holding Corporation35Q3 202352.0%
Q2 Holdings, Inc. (fka CBG Holdings, Inc.)35Q3 202336.6%
Corvus Pharmaceuticals, Inc.31Q3 202313.7%
Rimini Street, Inc.24Q3 202336.9%
Aptinyx, Inc.20Q1 202317.5%
magicJack VocalTec Ltd.(fka VocalTec Communications Ltd./Ymax Corporation)18Q4 201871.4%
Fusion Pharmaceuticals, Inc.14Q3 202311.4%
OncoMed Pharmaceuticals, Inc.12Q4 20177.5%
Icosavax, Inc.9Q3 202311.6%
Vacasa, Inc.8Q3 202324.0%

View ADAMS STREET PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ADAMS STREET PARTNERS LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Aptinyx Inc.June 27, 20235,395,9968.0%
Fusion Pharmaceuticals Inc.February 14, 20222,947,8096.8%
Rimini Street, Inc.February 14, 202223,659,43127.2%
Paylocity Holding CorpFebruary 14, 20201,738,4283.2%
Aptinyx Inc.February 13, 20194,030,62812.0%
Q2 Holdings, Inc.February 13, 20191,643,2753.8%
Corvus Pharmaceuticals, Inc.March 21, 20183,275,61615.5%
MAGICJACK VOCALTEC LTDFebruary 12, 20181,976,86112.3%
RIMINI STREET, INC.October 20, 201722,783,55638.9%
Five9, Inc.February 13, 20171,766,4703.0%

View ADAMS STREET PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13D/A2023-11-24
13F-HR2023-11-14
13F-HR2023-08-14
SC 13D/A2023-06-27
SC 13D/A2023-06-13
42023-06-08
13F-HR2023-05-15

View ADAMS STREET PARTNERS LLC's complete filings history.

Compare quarters

Export ADAMS STREET PARTNERS LLC's holdings